The Saudi Arabia Food & Drug Authority (SFDA) is reporting a safety signal for vertigo associated with use of levothyroxine, and recommends all healthcare professionals should be aware of this signal. …
Anzeige
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten